Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pollard

Showing results (921-930 of 992) with videos related to

Pageof 100
Sort By:
Science (New York, N.Y.)|April 13, 2013
Ribosomal protein SA haploinsufficiency in humans with isolated congenital aspleniaAlexandre Bolze, Nizar Mahlaoui, Minji Byun, et al.
Lancet (London, England)|August 23, 2014
Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trialRobert C Read, David Baxter, David R Chadwick, et al.
Cell Reports|May 4, 2023
Evaluation of T cell responses to naturally processed variant SARS-CoV-2 spike antigens in individuals following infection or vaccinationZixi Yin, Ji-Li Chen, Yongxu Lu, et al.
BMC Infectious Diseases|January 31, 2025
Evaluation of naturally occurring IgG anti-Vi antibody titers as predictors and correlates of typhoid fever in Dhaka, BangladeshFarhana Khanam, Natasha Y Rickett, Faisal Ahmmed, et al.
Lancet (London, England)|July 24, 2020
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trialPedro M Folegatti, Katie J Ewer, Parvinder K Aley, et al.
The Lancet. Infectious Diseases|September 26, 2024
The respiratory syncytial virus vaccine and monoclonal antibody landscape: the road to global accessJonne Terstappen, Sarah F Hak, Anant Bhan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 5, 2026
Protection Against Recurrent Typhoid Fever Conferred by a Prior Episode: Evidence from a Large Cohort Study in Dhaka, BangladeshFarhana Khanam, Joo-Young Esther Lee, Faisal Ahmmed, et al.
NPJ Vaccines|April 15, 2025
Risk analysis for outpatient experimental infection as a pathway for affordable RSV vaccine developmentE Z Siegal, J M H Schoevers, J Terstappen, et al.
The Lancet. Infectious Diseases|January 22, 2021
Meningococcal carriage in periods of high and low invasive meningococcal disease incidence in the UK: comparison of UKMenCar1-4 cross-sectional survey resultsJenny M MacLennan, Charlene M C Rodrigues, Holly B Bratcher, et al.
The Journal of Infection|May 29, 2017
An evaluation of purified Salmonella Typhi protein antigens for the serological diagnosis of acute typhoid feverNga Tran Vu Thieu, Tan Trinh Van, Anh Tran Tuan, et al.
Pageof 100

Showing results (921-930 of 992) with videos related to

Sort By:
Pageof 100
Science (New York, N.Y.)|April 13, 2013
Ribosomal protein SA haploinsufficiency in humans with isolated congenital aspleniaAlexandre Bolze, Nizar Mahlaoui, Minji Byun, et al.
Lancet (London, England)|August 23, 2014
Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trialRobert C Read, David Baxter, David R Chadwick, et al.
Cell Reports|May 4, 2023
Evaluation of T cell responses to naturally processed variant SARS-CoV-2 spike antigens in individuals following infection or vaccinationZixi Yin, Ji-Li Chen, Yongxu Lu, et al.
BMC Infectious Diseases|January 31, 2025
Evaluation of naturally occurring IgG anti-Vi antibody titers as predictors and correlates of typhoid fever in Dhaka, BangladeshFarhana Khanam, Natasha Y Rickett, Faisal Ahmmed, et al.
Lancet (London, England)|July 24, 2020
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trialPedro M Folegatti, Katie J Ewer, Parvinder K Aley, et al.
The Lancet. Infectious Diseases|September 26, 2024
The respiratory syncytial virus vaccine and monoclonal antibody landscape: the road to global accessJonne Terstappen, Sarah F Hak, Anant Bhan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 5, 2026
Protection Against Recurrent Typhoid Fever Conferred by a Prior Episode: Evidence from a Large Cohort Study in Dhaka, BangladeshFarhana Khanam, Joo-Young Esther Lee, Faisal Ahmmed, et al.
NPJ Vaccines|April 15, 2025
Risk analysis for outpatient experimental infection as a pathway for affordable RSV vaccine developmentE Z Siegal, J M H Schoevers, J Terstappen, et al.
The Lancet. Infectious Diseases|January 22, 2021
Meningococcal carriage in periods of high and low invasive meningococcal disease incidence in the UK: comparison of UKMenCar1-4 cross-sectional survey resultsJenny M MacLennan, Charlene M C Rodrigues, Holly B Bratcher, et al.
The Journal of Infection|May 29, 2017
An evaluation of purified Salmonella Typhi protein antigens for the serological diagnosis of acute typhoid feverNga Tran Vu Thieu, Tan Trinh Van, Anh Tran Tuan, et al.
Pageof 100